Does 5 Ht1b1d Agonists Triptans Interact with Sumatriptan?
CDI records a contraindicated classification for 5 Ht1b1d Agonists Triptans and Sumatriptan. The stored summary is: Coadministration of triptans with sumatriptan may have additive vasospastic effects. Use within 24 hours is contraindicated. The mechanism involves additive vasospastic effects. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Contraindicated
- Sumatriptan Class
- Serotonin-1b and Serotonin-1d Receptor Agonist
- Management
- Do not take together
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Additive vasospastic effects
What To Tell Your Doctor or Pharmacist
If you are taking 5 Ht1b1d Agonists Triptans and your doctor is considering prescribing Sumatriptan (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask about alternative medications that do not interact with your current regimen
- Ask how frequently you should be monitored while these are co-prescribed
- Never stop or change either medication without first consulting your healthcare provider